ASTM Insider Trading Activity and SEC Form 4 Filings
ASTM insider trading summary
No open-market insider purchases or sales of Aastrom Biosciences Inc (ASTM) have been reported on SEC Form 4 in the past 12 months.
Latest ASTM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 16, 2014 | Gerard J Michel | CFO and VP, Corp. Development | Buy | $51K (20,000 @ $2.55) |
| Sep 16, 2014 | Dominick Colangelo | President and CEO | Buy | $51K (20,000 @ $2.55) |
| Sep 16, 2014 | Daniel Orlando | Chief Operating Officer | Buy | $25K (9,804 @ $2.55) |
| Jan 4, 2012 | Scott Durbin | CFO | Sell | $72K (40,000 @ $1.80) |
| Aug 11, 2011 | Ronald M Cresswell | Director | Buy | $44K (20,000 @ $2.22) |
| Aug 11, 2011 | Scott Durbin | CFO | Buy | $22K (10,000 @ $2.24) |
| Aug 10, 2011 | Scott Durbin | CFO | Buy | $2K (850 @ $2.18) |
| Aug 8, 2011 | Timothy M Mayleben | President and CEO | Buy | $21K (10,000 @ $2.11) |
| Aug 5, 2011 | Timothy M Mayleben | President and CEO | Buy | $47K (20,000 @ $2.36) |
| Mar 24, 2011 | Ronald M Cresswell | Director | Buy | $44K (20,000 @ $2.19) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.